<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04263753</url>
  </required_header>
  <id_info>
    <org_study_id>174</org_study_id>
    <nct_id>NCT04263753</nct_id>
  </id_info>
  <brief_title>Bladder Conservative Surgery in r Abnormally Invasive Placenta With Bladder Invasion</brief_title>
  <official_title>Bladder Conservative Surgery in r Abnormally Invasive Placenta With Bladder Invasion With or Without Hematuria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Placental borders and mapping by ultrasonography and Doppler ultrasonography (placental&#xD;
      mapping) preop. And verified intraoperatively . bladder peritoneal dissection till the level&#xD;
      of internal Os Uterus is incised away from the placenta&#xD;
&#xD;
        -  Baby was delivered , the uterus is exteriorised and 4-5 towel clips are applied rapidly&#xD;
           control uterine incision site bleeding . Twenty units of diluted oxytocin and 100 to 200&#xD;
           cc, 37Â°C of heated saline were infused from here, and then the cord was clamped . Then&#xD;
           we proceed to systemically devascularize the uterus with the placenta in site After&#xD;
           control of both superior vesical vessels Finding a fresh noninvaded plan between&#xD;
           isthmocervical junction and posterior bladder wall aided by filling the bladder 150 cc&#xD;
           saline Then cervical stump control sutures and severing the specimen above the clamps&#xD;
&#xD;
      Now the placenta is only attached to the bladder , apply intestinal clamp or foley cath on&#xD;
      the bladder below the level of invasion if feasible to reduce bleeding&#xD;
&#xD;
        -  cut through the placenta, heavy back flow bleeding of old blood stored in the placenta&#xD;
           will be noticed , but there is no hemodynamic change since the cervical stump is already&#xD;
           severed&#xD;
&#xD;
           , dissect the bladder with a large safety margin cutting through the placenta.. Then in&#xD;
           cases with hematuria saline irrigation of the bladder is usually enough to clear the&#xD;
           hematuria 15 out of 20 In cases with larger blood clots in the bladder cystoscope is&#xD;
           done avoiding the need for cystotomy&#xD;
&#xD;
        -  lastly removal of excessive placental tissues from the bladder wall by gentle swabbing&#xD;
           or trimming, then individual control of bleeders and plication of the invaded area with&#xD;
           seromuscular purse string sutures around said area , in cases of large areas , bladder&#xD;
           mobilization is imperative to increase bladder capacity&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2020</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">March 9, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative blood loss</measure>
    <time_frame>during the operation</time_frame>
    <description>Blood loss = estimated blood volume (EBV) x preoperative hematocrit - postoperative hematocrit/preoperative hematocrit another method by weighing the towels and dressings before and after the procedure and adding the volume of fluid inside the suction apparatus</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Placenta Accreta With Bladder Invasion</condition>
  <arm_group>
    <arm_group_label>conservative surgery for bladder in placenta accretta</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bladder conservative surgery in placenta accretta</intervention_name>
    <description>After control of both superior vesical vessels Finding a fresh noninvaded plan between isthmocervical junction and posterior bladder wall aided by filling the bladder 150 cc saline Then cervical stump control sutures and severing the specimen above the clamps&#xD;
* Now the placenta is only attached to the bladder , apply intestinal clamp or foley cath on the bladder below the level of invasion if feasible to reduce bleeding&#xD;
* cut through the placenta, heavy back flow bleeding of old blood stored in the placenta will be noticed , but there is no hemodynamic change since the cervical stump is already severed&#xD;
, dissect the bladder with a large safety margin cutting through the placenta.. Then in cases with hematuria saline irrigation of the bladder is usually enough to clear the hematuria 15 out of 20</description>
    <arm_group_label>conservative surgery for bladder in placenta accretta</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Placenta accreta spectrum, with partial or total invasion With area of invasion more&#xD;
             than 7 cm in diameter&#xD;
&#xD;
          -  patient's informed consent about the future risks of conservative management&#xD;
&#xD;
          -  pregnancy &gt; 20 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  * deeply pelvic placenta accreta spectrum cases with cervical invasion , by&#xD;
             transvaginal ultrasound cervical length less than 21 mm&#xD;
&#xD;
               -  cases with total invasion in which the area of invasion is more than 20 min&#xD;
                  diameter&#xD;
&#xD;
               -  patient refusing conservative management and opting for hysterectomy&#xD;
&#xD;
               -  medical comorbidities making massive hemorrhage more likely such as&#xD;
                  coagulopathies&#xD;
&#xD;
               -  patient is in active antepartum hemorrhage&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed maged</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ahmed Maged</last_name>
    <phone>+201005227404</phone>
    <email>dr_ahmedmaged08@kasralainy.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>AbdAllah Mousa</last_name>
    <phone>+201274574588</phone>
    <email>dr_abdallamousa@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kasr Alainy medical school</name>
      <address>
        <city>Cairo</city>
        <zip>12111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Maged, MD</last_name>
      <phone>01005227404</phone>
      <email>prof.ahmedmaged@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 7, 2020</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed M Maged, MD</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

